🇺🇸 FDA
Patent

US 9468208

Disease control with tick phospholipase A2

granted A61KA61K38/00A61K38/465

Quick answer

US patent 9468208 (Disease control with tick phospholipase A2) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/465, A61P, A61P31/04